WG Hefner VA Medical Center
Salisbury, North Carolina 28144
1 studies enrolling now · 12 studies all time
What they study most
Breast Carcinoma, Chronic Kidney Disease, Colorectal Adenocarcinoma, Erectile Dysfunction, Estrogen Receptor Negative, KRAS Gene Mutation, Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Node Positive HER2 Negative Breast Cancer, Progesterone Receptor Negative, Recurrent Bladder Urothelial Carcinoma, Recurrent Lung Non-Small Cell Carcinoma
Studies at this site
- Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) — Running, not enrolling
- Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer — Running, not enrolling
- Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer — Running, not enrolling
- IT Matters: The Erectile Restoration Registry — Enrolling by invitation
- FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer — Completed
- Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy — Completed
- Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer — Running, not enrolling
- Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer — Stopped early
- Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer — Completed
- Evaluation of Mammographic Breast Density in Participants with Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502 — Stopped early
- Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy — Stopped early
- A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1) — Completed